Worth noting:

Crinetics Pharmaceuticals submits Acromegaly new drug paltusotine for FDA approval . Read more

Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more 

News from Recordati on osilodrostat for endogenous Cushing’s – More details here

Corcept Therapeutics reports significant results in Cushing’s drug trial.  Read more

New support site from Chiesi; Rethink acromegaly

Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.

Chiesi relaunches a patient-facing website for Mycapssa.

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

Live Talk on Demand

Today’s podcast brings together two leading experts in mental health and pituitary disease for an in-depth round-table discussion of mental and emotional issues that affect people daily.

Listen in your favorite platform